TXMD
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel, CEO
General Counsel
TherapeuticsMD, Inc. (TXMD)Equibles does not estimate personal net worth.
Get an email with a short summary when TherapeuticsMD, Inc. publishes a filing, an earnings call transcript or a press release.
Get TXMD alertsMarlan D. Walker is recorded as General Counsel and CEO at TherapeuticsMD, Inc. (TXMD). The newest filing on record that lists Marlan D. Walker as CEO at TherapeuticsMD, Inc. (TXMD) is dated November 3, 2025. The newest filing on record that lists Marlan D. Walker as General Counsel at TherapeuticsMD, Inc. (TXMD) is dated April 14, 2021. The proxy statement of TherapeuticsMD, Inc. reports total compensation of $759,174 for Marlan D. Walker in fiscal 2024, including a base salary of $500,000. Disclosed compensation is on record for 4 fiscal years. TherapeuticsMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at TherapeuticsMD, Inc. includes Brian Bernick (CEO), Mark Glickman (CEO), Robert Finizio (CEO and Board Member) and 7 others.
Start not stated–present
Last confirmed April 14, 2021
Start not stated–present
Last confirmed November 3, 2025
TXMD
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | TherapeuticsMD, Inc. (TXMD) | Chief Executive Officer | $500,000 | $759,174 |
| 2023 | TherapeuticsMD, Inc. (TXMD) | Chief Executive Officer | $476,462 | $1,019,817 |
| 2022 | TherapeuticsMD, Inc. (TXMD) | Chief Executive Officer | $424,500 | $1,573,380 |
| 2021 | TherapeuticsMD, Inc. (TXMD) | Chief Executive Officer | $415,000 | $1,597,193 |
No call appearances or filed executive changes recorded yet.